MIBG molecular imaging for evaluating response to chemotherapy in patients with malignant pheochromocytoma: preliminary results

Malignant pheochromocytomas respond to chemotherapy with a reduction in tumor size and catecholamine secretion. We investigated the usefulness of molecular imaging with meta-iodobenzylguanidine (MIBG) for evaluating the effects of chemotherapy in patients with malignant pheochromocytoma. Six patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurea, Simone, Fiumara, Giovanni, Pellegrino, Teresa, Zampella, Emilia, Assante, Roberta, Mainenti, Pierpaolo, Cuocolo, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: e-Med 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629891/
https://www.ncbi.nlm.nih.gov/pubmed/23598367
http://dx.doi.org/10.1102/1470-7330.2013.0017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629891/
https://www.ncbi.nlm.nih.gov/pubmed/23598367
http://dx.doi.org/10.1102/1470-7330.2013.0017

Ejemplares similares